Physician profile
David Eugene Fumo
NPI 1164463725
$1,427.62
in general payments reported to CMS, 2019-2025
20 companies · $48.12 in 2025
The $48.12 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $181 · 2021: $112 · 2022: $70.93 · 2023: $170 · 2024: $148 · 2025: $48.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $354.89 | 2021-2025 | Visiglide, Endocapsule Recorder, Single Use Aspiration Needle Na-U200h |
| Boston Scientific Corporation | $153.95 | 2019-2021 | |
| Karl Storz Endoscopy-America | $149.99 | 2019 | |
| Medical Device Business Services, INC. | $148.43 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.42 | 2019 | |
| Abbvie INC. | $91.50 | 2019-2021 | |
| Medtronic, INC. | $88.13 | 2023 | Endoflip |
| Ucb, INC. | $59.09 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.74 | 2019 | |
| Merck Sharp & Dohme LLC | $39.75 | 2019-2020 | |
| Pfizer INC. | $30.03 | 2019 | |
| Covidien LP | $24.05 | 2019 | |
| Vivus LLC | $20.13 | 2020 | |
| Ethicon US, LLC | $16.68 | 2020 | |
| Astellas Pharma US INC | $15.13 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dova Pharmaceuticals | $15.04 | 2019 | |
| Shire North American Group INC | $13.83 | 2019 | |
| Intercept Pharmaceuticals, INC. | $12.77 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.73 | 2022 | |
| Janssen Biotech, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fumo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.